BMRNNasdaqPharmaceutical Preparations

BioMarin Pharmaceutical Inc (BMRN) earnings date, market-implied expected move, and options open interest by expiry

57.43

pre 55.56 −0.18%

Pre-market04:18 ETdelayed

Open58.93Volume3.3MMkt cap$11.1BP/E146.21EPS0.38

Day55.56 – 58.930%52-wk49.26 – 70.9829%

BMRN

BioMarin Pharmaceutical Inc

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

No implied move.

Expected move

Inputs

Next report

Feb 22

after close · in 110 days

est.Q4 FY26

Calendar

Next report

Last report

−3.10%

vs ±6.6% implied · ×0.47

shaded = implied · ▲▼ = realized

Nov 2 '26 · confirmed

Implied vs realized

Linked news

4dSNY · customerSanofi Q3 sales €14,444 million, business EPS €3.55; upgrades 2026 guidance

News

Largest filed tie

13F top-10 QoQ

+4.38%

shares held · 10 largest managers

13F · Jun 30 '26127d lag

565 managers

Top fund weight

0.94%

BMRN weight · XBI

N-PORTJun 30 '26

5 funds

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

BioMarin Pharmaceutical (BMRN) is expected to report on Feb 22 after close (estimated date).

Implied vs realized

2 reports

—≥ implied

Q2 FY26Aug 6 '26confirmed±8.2%▲+3.82%×0.47

Q3 FY26Nov 2 '26confirmed±6.6%▼−3.10%×0.47

quarterimplied−10%0+10%realized×

Q3 FY26±6.6%▼−3.10%×0.47

Q2 FY26±8.2%▲+3.82%×0.47

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 4 expiries · Nov 3 close

0.22OI · 4 expiries · Nov 3 closeP/C open interest · Apr 16 · first expiry after the report

PUTS · chgexpiry · days · P/CCALLS · chgP/C

1,389+46%Nov 2016d0.314,554+34%0.31

524+1%Dec 1844d0.281,874+27%0.28

5,176+1%Jan 1572d0.4611,2790%0.46

report · Feb 22 · after close · est.

7490%Apr 16163d3,443+8%

ExpiryPutsCallsP/C

Nov 2016d1,389+46%4,554+34%0.31

Dec 1844d524+1%1,874+27%0.28

Jan 1572d5,176+1%11,2790%0.46

report · Feb 22 · after close · est.

Apr 16163d7490%3,443+8%0.22

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

No implied move.

Linked exposure

Revenue flow

as filedQ3 FY26

−11.99%as filednet margin · revenue +3.53% QoQ · +32.02% YoY

Revenue$1.0B+3.53%

Gross profit$819M79.95%+4.11%

Operating income−$82M−8.01%−174.00%

Pre-tax income−$132M−314.66%

Net income−$123M−11.99%−374.41%

Cost of revenue$205M+1.29%

Operating expenses$901M+33.33%

Tax−$9M−153.77%

Other expense−$50M−0.31%

Source: SEC filings · standardized · QE Sep 30 '26 · bars = % of revenue

Revenue flow

Intraday

15m bars

Hatch = extended hours · ▯ up · ▮ downSource: market data · 04:15 ET

Intraday

Event sensitivity

CPI ×1.05· ±1.5% vs ±1.4% · 10 releases

eventrelease day|move|up · n×base

CPIconsumer prices±1.5%4 of 10×1.05

NFPjobs report±1.4%6 of 10×0.99

PPIproducer prices±1.3%6 of 10×0.91

FOMCrate decision±1.2%12 of 24×0.88

CPROFcorporate profits±1.1%7 of 12×0.82

PCEpersonal income & outlays±1.1%10 of 19×0.80

GDPgross domestic product±1.0%12 of 19×0.71

Bar = avg |move| to ±2% · tick = ±1.4% avg day · ×base = |move| ÷ ±1.4% · min 6 releases

Earnings history

EPS -0.63 · consensus —

Quarter	Reported	EPS	Consensus
Q3 FY26	Nov 2 '26 · confirmed	-0.63	—
Q2 FY26	Aug 6 '26 · confirmed	0.23	—
Q1 FY26	—	0.54	—
Q3 FY25	—	-0.16	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod